Patents
Patents for C07C 279 - Derivatives of guanidine, i.e. compounds containing the group the singly-bound nitrogen atoms not being part of nitro or nitroso groups (5,394)
07/2001
07/31/2001US6268516 Cationic amphiphilic lipids for liposomal gene transfer
07/31/2001US6268387 Inhibitors of the enzyme 15-lipoxygenase and are inhibitors of monocyte chemotaxis.
07/26/2001WO2001053276A1 Dihydrofolate reductase inhibitors
07/26/2001WO2001053201A1 Nonaborate compositions and their preparation
07/24/2001US6265610 Contrast media for angiography
07/24/2001CA2085465C Thrombin inhibitors based on the amino acid sequence of hirudin
07/19/2001WO2001051458A1 Method for producing n-methyl-n'-nitroguanidine
07/19/2001WO2001044172A8 Salicylamides as serine protease and factor xa inhibitors
07/19/2001DE10000891A1 Verfahren zur Herstellung von N-Methyl-N'-nitroguanidin A process for the preparation of N-methyl-N'-nitroguanidine
07/18/2001EP1116712A1 Amine derivatives and skin preparations for external use containing the same
07/18/2001EP0850221B1 Meta-guanidine, urea, thiourea or azacyclic amino benzoic acid derivatives as integrin antagonists
07/18/2001CN1068587C Ortho-substituted benzoic acid derivatives
07/18/2001CN1068585C Cationic lipids for gene therapy
07/18/2001CN1068583C N-acyl-2 aryl cyclopropylmethylamine derivatives as melatonergics
07/17/2001US6262123 Ortho-substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament comprising them
07/17/2001US6262122 Enantiomers of 4-[[(cyanoimino) [(1,2,2-trimethylpropyl)amino]methyl]amino]benzonitrile
07/12/2001WO2001049721A2 Bacterial genes and proteins that are essential for cell viability and their uses
07/12/2001US20010007913 A pressed rocket motor charge containing guanylurea dinitramide as gas generator as main component for vehicle safty equipment such as airbag; good stability, generates no noxious gases
07/12/2001CA2396040A1 Novel bacterial genes and proteins that are essential for cell viability and their uses
07/11/2001CN1303365A Benzamide and sulfonamide substituted aminoguanidines and alkoxyguanidines as protease inhibitors
07/11/2001CN1068308C Substituted benzoylguanide, its preparing process and medicine and application of same
07/10/2001US6258976 Process for the preparation of polyamines and polyamine derivatives
07/10/2001CA2040947C Platelet-aggregation inhibitors
07/05/2001WO2001010849A3 Substituted arylalkylamino-1,3,5-triazines as herbicides
06/2001
06/28/2001WO2001046129A2 Method for producing nitroguanidine
06/28/2001DE19962227A1 Verfahren zur Reinigung von Kreatin A process for purifying creatine
06/27/2001EP1110948A2 Polyhexamethyleneguanidine phosphate powder, method of making the same and antimicrobial resin containing the same
06/27/2001EP1110947A1 Process for the purification of creatine
06/27/2001EP0749960B1 Process for the synthesis of cationic surfactants obtained from the condensation of fatty acids with esterified dibasic aminoacids
06/27/2001EP0733046B1 benzoyl guanidines, their production and their use in medicaments
06/27/2001CN1300731A 3-methyl-2-butenyl isoguanidine as active hypoglycemic component in Yanzizhang and its preparing process
06/27/2001CN1067550C Calcium receptor active molecules
06/26/2001US6251948 Trisubstituted guanidine useful for treating diseases of the nervous system in which the pathophysiology of the disease involves excessive excitation of nerve cells by agonists of glutamate/n-methyl-d-aspartate receptor
06/26/2001US6251944 (vitronectin receptor) integrin antagonist, useful for treating angiogenesis, tumor growth, tumor metastasis, osteoporosis and humoral hypercalcemia of malignancy
06/21/2001WO2001044172A1 Salicylamides as serine protease and factor xa inhibitors
06/21/2001CA2394639A1 Salicylamides as serine protease and factor xa inhibitors
06/20/2001EP0889875B1 Cyclopropyl alkanoic acid derivatives
06/20/2001CN1300303A Enzyme inhibitors
06/14/2001WO2001042199A1 Amidinophenylpyruvic acid derivative
06/14/2001WO2001042192A2 Vla-4 integrin antagonists
06/14/2001CA2388686A1 Vla-4 integrin antagonists
06/13/2001EP1106602A1 Simulated moving bed chromatographic purification of amino acids
06/13/2001CN1299343A Biphenyl derivatives
06/12/2001US6245359 Active agent transport systems
06/12/2001CA2044978C Platelet-aggregation inhibitor
06/07/2001WO2001030749B1 Novel compounds
06/07/2001US20010003001 Compounds and compositions for delivering active agents
06/06/2001CN1066718C Substituted aryloxy-alkyl diamines and its producing process and use
06/05/2001US6242198 Methods of treatment of eye trauma and disorders
05/2001
05/23/2001EP1101763A2 Method for preparing sodium-hydrogen exchanger type 1 inhibitor
05/23/2001EP1101496A1 Therapeutic agents for allergic diseases
05/22/2001US6235934 Aqueous hexasubstituted guanidinium chlorides and methods for their preparation and use
05/22/2001US6235778 Anticoagulants
05/16/2001CN1295070A Process for prep. of 1-type sodium-hydrogen exchange agent inhibitor
05/16/2001CN1065861C Phenyl substituted alkenocarboxylic guanidine, preparation method application as medicine or diagnostic agent and medicine containing it
05/10/2001WO2001032717A2 Initiator/amidine complexes, systems comprising the complexes, and polymerized compositions made therewith
05/10/2001WO2001032611A1 N-guanidinoalkylamides, their preparation, their use, and pharmaceutical preparations comprising them
05/09/2001CN1065527C Guanidine derivatives, process for producing same and cosmetics contg. same
05/09/2001CN1065526C Process for preparing N-methyl-N'-nitroguanidine
05/03/2001WO2001030749A1 Novel compounds
05/03/2001WO2001030148A1 Novel substituted succinic acid metallo-beta-lactamase inhibitors and their use in treating bacterial infections
05/02/2001EP1095933A1 Novel N-guanidinoalkylamides, their preparation, their use, and pharmaceutical preparations comprising them
05/02/2001EP1094812A1 Angiogenesis inhibitors
05/02/2001EP0743853B1 Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases
05/01/2001US6225341 For inhibiting neuraminidase; for therapy and prophylaxis of virus infection
04/2001
04/29/2001CA2324640A1 Method for preparing sodium-hydrogen exchanger type 1 inhibitor
04/26/2001WO2001028979A2 Inhibitors of neuraminidases
04/26/2001WO2000078737A3 Aryloxy ethylamino triazines as herbicides
04/25/2001CN1064956C Ortho-substd. benzoyl guanidine, its preparing method, use thereof and medicine contg. same
04/25/2001CN1064955C Fluorine-containing benzoylguanidines
04/25/2001CN1064954C Orthosubstituted benzoylguanidine, preparation of same, pharmaceutical containing same and application of same
04/24/2001US6221367 Exposing a biologically active agent to a complexing perturbant to reversibly transform the biologically active agent to the intermediate state and to form a transportable supramolecular complex
04/18/2001EP1091942A1 Potassium channel blocking agents
04/18/2001CN1064676C Ortho-substituted benzoyl guanidine, its preparation, use and medicines containing it
04/17/2001US6218426 For therapy of mammalian reproductive disorders and steroid hormone-dependent tumors as well as for regulating fertility, where suppression of gonadotropin release is indicated
04/12/2001WO2001025486A1 Methods for identifying rna binding compounds
04/12/2001WO2001025188A1 Novel carbamates and ureas
04/12/2001DE19946597A1 Stabilisiertes Guanidinlthiocyanat und dessen Verwendung Stabilized Guanidinlthiocyanat and its use
04/12/2001CA2386540A1 Novel carbamates and ureas
04/12/2001CA2386239A1 Methods for identifying rna binding compounds
04/11/2001EP1089967A1 Novel compounds useful in pain management
04/11/2001EP1089966A1 Novel compounds useful in pain management
04/11/2001CN1064352C Novel cyloakyl derivatives and inhibitors of bone resorption and vitronection receptor antagonists
04/11/2001CN1064351C Substituted indanylidineacetylguanidine, process for their paraparation, their use as medicaments ofdiagonstic and medicaments containing them
04/05/2001WO2001023348A1 Stabilized guanidine thiocyanate and the use thereof
04/04/2001EP1087948A1 2,4-diamino-1,3,5-triazine, method for the production and use of the same as herbicides and plant growth regulators
04/04/2001EP1087940A1 Novel compounds useful in pain management
04/03/2001US6211407 Dicreatine citrate comprising two creatine cations per citrate dianion
04/03/2001US6211245 Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases
04/03/2001US6211228 Compositions and methods for treating mast-cell mediated conditions
04/03/2001US6211186 Polyoxyalkylene glycol modified with n-heterocycle derivative with amidine or guanidine group; diaper rash, obesity, acne, periodontal disease, contraceptives; protease and lipase inhibitors
03/2001
03/29/2001WO2001021582A1 Biphenyl derivatives used as nhe-3 inhibitors
03/29/2001WO2000059875A3 Novel inhibitors of formation of advanced glycation endproducts (age's)
03/29/2001DE19945302A1 Biphenylderivate als NHE-3-Inhibitoren Biphenyl as NHE-3 inhibitors
03/29/2001CA2387529A1 Biphenyl derivatives as nhe-3 inhibitors
03/28/2001CN1063744C 15-deoxyspergulin analogs, their method of preparation and their use in therapeutics
03/27/2001US6207663 Vitronectin receptor antagonists, their preparation and use
03/22/2001WO2000068229A3 (s)-benzoquinolizine carboxylic acids and their use as antibacterial agents
03/21/2001EP1085011A1 Novel polyamine analogues as therapeutic and diagnostic agents
03/21/2001CN1063438C Alkenyl-benzoyl guanidine derivant, prepn. method and use thereof
1 ... 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 ... 54